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Abstract
We have previously identified and characterized Drosophila hemolectin (Hml) in the conditioned medium of a Drosophila cell line. The
deduced amino acids sequence contains a number of domains conserved in human von Willebrand factor, coagulation factor V/VIII, and
complement factors. To characterize Hml localization and function, we have established two transgenic lines (hml-GAL4 and UAS-
hmlRNAi). By crossing hml-GAL4 with UAS-eGFP, we observed that Hml is specifically expressed in embryonic and in larval hemocytes.
We determined that Hml is expressed in a subpopulation of plasmatocytes and crystal cells but not in lamellocytes. hml RNAi larvae are
viable and do not display obvious developmental defects under normal conditions. However, they show a bleeding defect upon injury. We
confirmed that the failure to seal a wound is not due to a defect in melanin production or in phenoloxidase activity. The expression of
amtimicrobial peptides was not significantly affected on hml RNAi adults. Altogether, our data strongly suggest that Hml is involved in
hemostasis and/or coagulation in Drosophila larvae.
© 2003 Elsevier Inc. All rights reserved.
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Introduction
Insects are extremely resistant to microbial infection.
Drosophila is one of the model organisms in which the
mechanisms of innate immunity are highly conserved with
that of mammals (Hoffmann and Reichhart, 2002; Khush
and Lemaitre, 2000). The host defense in Drosophila is
mainly classified into three facets: (1) a humoral response in
which a cocktail of antimicrobial peptides are secreted from
the fat body, a functional equivalent of mammalian liver,
into the circulation; (2) activation of proteolytic cascades
which lead to blood coagulation and melanization; and (3) a
cellular response which includes phagocytosis and encap-
sulation by blood cells (hemocytes) (reviewed in Hoffmann
et al., 1999). Although the humoral response has been well
analyzed, the mechanisms of blood coagulation and cellular
responses have not been explored extensively.
Drosophila larvae produce three major hemocyte types:
plasmatocytes, lamellocytes, and crystal cells (Lanot et al.,
2001). Plasmatocytes represent the majority of circulating
hemocytes (95%). They are small round shaped with
phagocytic capacities. Lamellocytes are very large and flat-
tened cells responsible for encapsulation of large-sized in-
vaders (e.g., eggs). Crystal cells, distinguished by the pres-
ence of crystal-like inclusions in the cytoplasm, are
proposed to contain the substrate and enzymes for the mel-
anization cascade.
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1 Two hml-GAL4 lines (w1118; P{w  mC  GAL4-Hml} 5-6 and
w1118; P{w  mC  GAL4-Hml}6-4) and one homozygote of d-hml-
GAL4, UAS-gfpnlacZ, UAS-gfp[S65T]/d-hml-GAL4, UAS-gfpnlacZ, UAS-
gfp[S65T] (w1118; P{w  mC  GAL4-Hml} 6-4 P{w  mC 
UAS-GFP::lacZ.nls} 15.1) transgenic lines are available from the Bloom-
ington Stock Center with the stock numbers of 6395, 6396, and 6397,
respectively.
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Two phases of Drosophila hematopoiesis are proposed
to occur successively at the embryonic and at the larval
stage. The embryonic hemocytes appear in the anterior
mesoderm at midembryogenesis, proliferate, and distribute
into the whole embryo while they are differentiating into
macrophages responsible for the phagocytosis of apoptotic
cells (Hartenstein and Jan, 1992; Tepass et al., 1994; Franc
et al., 1999). Toward the end of embryogenesis, the larval
hematopoietic organ referred to as lymph glands, which are
composed of paired lobes, develops along the anterior por-
tion of the dorsal vessel, and is proposed to produce larval
hemocytes (Rizki and Rizki, 1984; Lanot et al., 2001).
However, due to the lack of specific molecular markers, our
knowledge of larval hemocytes is still fragmentary. More-
over, in spite of extensive biochemical studies on proph-
enoloxidase (proPO) cascade and hemolymph coagulation
in silk worm and horseshoe crab (reviewed in Ashida and
Brey, 1997; Iwanaga et al., 1998), these processes are
poorly characterized in Drosophila, although a serpin that
controls the proPO cascade has recently been described (De
Gregorio et al., 2002; Ligoxygakis et al., 2002).
We have recently identified a novel Drosophila protein
of 400 kDa, Hemolectin (Hml), as a secreted protein from
a Drosophila cell line Kc167 (Goto et al., 2001b). In this
study, to characterize hml localization and function in vivo,
we have generated two transgenic fly lines (hml-GAL4 and
UAS-hmlRNAi). By crossing hml-GAL4 with UAS-eGFP,
we show hemocyte-specific hml expression in a subpopula-
tion of plasmatocytes and crystal cells. Furthermore, we
evidenced a bleeding defect in larvae by suppressing hml
expression using heritable and tissue-specific RNA interfer-
ence technique (Bass, 2000; Carthew, 2001).
Materials and methods
DNA construction for transgenes
pP {hml-GAL4} was constructed by combining the
BamHI–NotI fragment of GAL4 excised from pGaTB
(Brand and Perrimon, 1993) and the 3.0-kb upstream pro-
moter region of hml and cloning into pCaSpeR 4 vector
(Thummel and Pirrotta, 1992). The promoter region of hml
flanked by BamHI site at both ends was prepared by am-
plification of genomic DNA using paired primers of 5-
CGC GGA TCC AAG AAC TTT ACA TAA ATT CCG
GTA TC-3 (forward) and 5-CGC GGA TCC TTT GTT
AGG CTA ATC GGA AAT TGT TGG-3 (reverse) based
on the sequence nt 20501-23450 in AC015143 of GenBank.
To generate pP {UAS-hml RNAi} having inverted repeat of
5 region of hml cDNA (Goto et al., 2001b) under the
control of UAS, two RT-PCR fragments of hml cDNA were
prepared. One fragment having EcoRI site at nt 163 end and
SpeI site at nt 470 end was prepared by using paired primers
of 5-GCC CGG AAT TCA TGG CTA ACA AAG TGA
TTT TTG TGG CG-3 (forward) and 5-CCT AGA CTA
GTA AAA AAA GAC GTC TTT ATC CCG CCA TAA
CCA C-3 (reverse). Another fragment having XhoI site at
nt 163 end and SpeI site at 470 end was prepared by using
paired primers of 5-CGC CGC TCG AGA TGG CTA ACA
AAG TGA TTT TTG TGG CG-3 (forward) and 5-CCT
AGA CTA GTA AAA AAA AGA CGT CTT TAT CCC
GCC ATA ACC ACC-3 (reverse). Two A7 (or T7) were
added to both SpeI sites to create a hinge for the formation
of hairpin-shaped dsRNA structure. Two PCR products
were ligated and inserted into the EcoRI and XhoI sites of
pUAST vector (Brand and Perrimon, 1993) after digestion
with EcoRI and XhoI.
Fly lines and crosses
hml-GAL4 and UAS-hml RNAi transgenic flies were
made by the standard method (Spradling and Rubin, 1982).
Several independent transgenic lines were established for
each transgene. All gave similar phenotypes. To identify
hml-expressing cells, hml-GAL4 virgin females were
crossed with males with a genotype of UAS-gfpnlacZ, UAS-
gfp[S65T]/CyO (referred to UAS-eGFP). To detect partial
loss-of-function phenotypes of hml, hml-GAL4 males were
crossed with UAS-hml RNAi virgin females. As the nega-
tive control, yw males were crossed with UAS-hml RNAi
virgin females.
Northern blotting
Total RNA was extracted from hemolymph containing
mainly hemocytes, gut, fat body, and adults by TRIzol
reagent (Gibco-BRL). Total RNAs corresponding to 10 g
(20 g in the case of adults) were separated on a 1%
agarose–formaldehyde gel, blotted to Hybond-N nylon
membrane (Amersham Pharmacia Biotech), and hybridized
to a [32P]-labeled RT-PCR hml cDNA probe (GenBank
AB035891, nt 6532-7260), Drosomycin (Drs) or Diptericin
(Dip) (Lemaitre et al., 1996) at 42°C in 5 SSPE containing
0.5% SDS, 5 Denhardt’s solution, 50% formamide, and
0.1 mg/ml of denatured salmon sperm DNA for 16 h. The
membrane was washed twice with 2 SSC containing 0.1%
SDS at room temperature and twice with 0.1 SSC con-
taining 0.1% SDS at 55°C for 30 min, and analyzed with a
Fuji Film BAS 2000 Image Analyzer. After removing hml
cDNA probe from the filter with 0.5% SDS at 80°C, ribo-
somal protein Rp49 [32P]-labeled cDNA probe was hybrid-
ized to obtain the signal of internal control.
Whole-mount immunostaining
The staining was performed essentially as described in
the textbook by Ashburner, (1989). Briefly, specimens con-
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taining both embryos and first instar larvae were fixed with
a mixture of 4% paraformaldehyde and heptan for 5 min,
washed with heptan three times, vitelline membrane was
removed with a mixture of methanol and heptan for 5 min,
washed with methanol, dried and washed with 0.1% Tween
20 in PBS (PT), and weakly sonicated in PT for the perme-
abilization of antibody. After blocking nonspecific binding
sites with 5% normal goat serum in PT for 30 min, speci-
mens were incubated overnight with mouse antiserum
against Peroxidasin (gift from Drs. L.I. Fessler and J.H.
Fessler) in PT, washed with PT, and reacted with rhodam-
ine-labeled second antibody (CHEMICON) for 1 h. After
washing, specimens were embedded in 80% glycerol con-
taining 2.5% DABCO (Sigma) for confocal fluorescence
microscopy (Bio-Rad, MRC1024). For proPO staining,
lymph glands from third instar larvae were dissected in PBS
and fixed 20 min in 4% paraformaldehyde on ice. After
several rinses in PBT (PBS  0.1% Tween 20), they were
blocked for 2 h in PBT–3% BSA at room temperature, then
incubated in antibody at the appropriate dilution [rat anti-
proPO (Mu¨ller et al., 1999) at 1:500 and rabbit anti-GFP at
1:500] in PBT-BSA overnight at 4°C. Several rinses in PBT
were followed by a 2-h incubation in secondary antibody at
4°C (Alexa Fluor 546 goat anti-rat IgG and Alexa Fluor 488
goat anti-rabbit IgG diluted 1:500, Molecular Probes), then
five rinses in PBT. The lymph glands were finally mounted
in Vectashield (Vector Laboratories) fluorescent mounting
medium.
Parasitoid wasp and microbial infection
L. boulardi egg-laying was allowed on Drosophila sec-
ond instar larvae, and the subsequent observations were
performed on late third instar larvae (Chiu et al., 2001). For
microbial infection, flies were pricked with a thin tungsten
needle that had previously been dipped into a concentrated
culture of either a Gram-positive bacteria, Micrococcus
luteus (M. luteus) or a Gram-negative bacteria, Eschericia
coli (E. coli) strain 1106. Flies were collected after either 24
or 6 h for Gram-positive and Gram-negative bacteria infec-
tion, respectively (Lemaitre et al., 1996).
SDS electrophoresis and Western blotting
SDS gel electrophoresis was performed by using 5%
polyacrylamide gels as described (Laemmli, 1970). For
Western blotting, 20 third instar larvae from either control
or hml RNAi were homogenized in SDS sample buffer,
boiled, and centrifuged at 10,000g for 5 min to obtain the
supernatant for electrophoresis. Separated proteins in the
gel were transferred to a nitrocellulose membrane. The
membrane was blocked with 5% skim milk and 0.1%
Tween 20 in PBS for 1 h, reacted with monoclonal antibody
against Hml (Goto et al., 2001b; Kumagai et al., 2000) for
16 h at 4°C, washed, and reacted with 1000-fold diluted
horseradish peroxidase-conjugated anti-mouse or anti-rabbit
immunoglobulin for 1 h. The same membrane was stripped
with elution buffer (0.2 M glycine, pH 2.8, 1 mM EGTA),
neutralized with PBS, and reblotted with antisera against
laminin  chain (Kumagai et al., 1997). The ECL Western
blotting system (Amersham Pharmacia Biotech) was used
for detection.
Bleeding test of larva
Third instar larvae were placed on an ice-chilled glass
plate and gently pricked once with a fine tungsten needle.
Thirty-five injured larvae were transferred to a piece of wet
filter paper dampened by minimum hemolymph-like solu-
tion (70 mM NaCl, 5 mM KCl, 1.5 mM CaCl2, 20 mM
MgCl2, 10 mM NaHCO3, 5 mM trehalose, 115 mM sucrose,
5 mM Hepes, pH 7.2) (Stewart et al., 1994) in 35-mm
plastic dish cooled on ice and kept for 3 h to let them
continue to bleed. After 3 h of bleeding, the larvae were
removed from the filter paper and the filter paper was kept
at 25°C for an additional 3 h to proceed the melanization
reaction. At least three independent bleeding experiments
using different chromosome P-element insertion lines were
performed, and all showed the same results.
Measurement of melanin production and PO activity
In order to know the potential effect of a hml knock down
on the melanization reaction, the following analysis was
carried out. Seven larvae of control or hml RNAi were
washed with distilled water, dried, and dissected to collect
hemolymph. A total of 1.3 l of hemolymph sucked up with
micropipet was immediately mixed with 1 l of 1 mg/ml
LPS solution already spotted on slide glass and kept at 18°C
to proceed melanization under humid conditions. These
procedures were repeated with 2 min of interval to obtain
altogether six spots within 10 min. A photograph of the
spots was taken after 1 h. Three independent experiments
have been carried out. To measure PO activity, hemolymph
from adult flies was collected 4 h following infection, and
the protein concentration was determined by using Bradford
assay. Measurements were performed in 96-well plates as
follows: 10 g of protein was suspended in 40 l of PBS
containing protease inhibitors. One hundred and twenty
microliters of a saturated solution of L,3-4-dihydroxyphe-
nyl-alanine (L-DOPA) were added in each sample. OD mea-
surements were taken after 5 min at 492 nm (Ligoxygakis et
al., 2002). Mean values are shown with their respective
error bars. Flies were challenged by using a mixture of
Gram-negative (E. coli) and Gram-positive (M. luteus) bac-
teria.
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Results
Hml expression in larvae
Hml was originally found as a secreted protein from a
Drosophila cell line Kc167 (Goto et al., 2001b). Since
Northern blot analysis during Drosophila development in-
dicated that hml is expressed mainly at larval stages, first
instar larvae were stained with a specific monoclonal anti-
body against Hml (Goto et al., 2001b; Kumagai et al.,
2000). Strong staining was observed in hemocytes, and a
weak fluorescence which could correspond to auto-fluores-
cence was also recorded in the gut (Fig. 1A). To ascertain
whether the expression was specific to hemocytes, total
RNA of hemolymph containing mainly hemocytes, gut, and
fat body dissected from third instar larvae was extracted and
analyzed by Northern blot (Fig. 1B). hml expression was
evidenced in hemocytes only.
hml promoter drives GAL4 expression in hemocytes
We wanted to follow hml expression at the transition
between embryonic and larval stages. To simplify observa-
tion, we generated a transgenic line (hml-GAL4) in which
the yeast transcription factor GAL4 is expressed under the
control of 3 kb of upstream hml promoter sequence. We
crossed these flies with UAS-eGFP transgenic flies to visu-
alize hml expression with GFP. Immunostaining experi-
ments with Hml mAb in first instar larvae confirmed that
Hml-positive cells correspond to GFP-positive cells, indi-
cating that GFP expression reflects endogenous hml expres-
sion (data not shown). A reduced population of GFP-posi-
tive cells is already observed in stage 17 embryos (Fig. 2A
and B), and these cells are significantly more numerous just
prior to hatching (Fig. 2C and D). The localization of the
GFP-positive cells in embryos suggests that they are plas-
matocytes, and it is also likely that these cells correspond to
the previously described embryonic hemocytes (Tepass et
al., 1994). Consistent with the result of immunostaining
data (see Fig. 1A), hemocyte-specific GFP expression was
observed in first instar larvae (Fig. 2E and F). Hemocyte-
specific GFP expression is found at all larval stages, until
pupariation, and disappears at metamorphosis. Although we
also could observe GFP expression on adults hemocytes in
the leg and abdominal regions, the expression was very
weak compared with larval hemocytes (data not shown). In
third instar larvae, we observed GFP expression in segmen-
tally distributed sessile hemocytes (Fig. 2G) (Lanot et al.,
2001) together with circulating hemocytes, directly in live
larvae. In addition, the expression was detected in a variable
number of cells in the anterior lobes of the lymph glands,
but never in the posterior lobes which contain mainly pro-
hemocytes (Fig. 2H and I). This expression profile is in
good agreement with hml expression data as analyzed by
RT-PCR (Goto et al., 2001b). All independent transgenic
lines showed the same expression pattern, indicating that it
Fig. 1. hml expression in larvae. (A) First instar larva stained with an anti-Hml specific monoclonal antibody. Hemocyte-specific staining was observed. Bar,
50 m. (B) Total RNA (10 g) extracted from hemolymph (containing mainly hemocytes), gut, and fat body from third instar larvae was hybridized with
a radio-labeled hml cDNA probe. The lower panel shows an internal control, Drosophila ribosomal protein Rp49.
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is not due to the effect of local P-element insertion site (data
not shown).
We further investigated whether hml is expressed in all
plasmatocytes, and if its expression is restricted to this
hemocyte lineage. Interestingly, in third instar larvae, not all
plasmatocytes in circulation express hml (Fig. 3A and B,
asterisks). Colocalization experiments of GFP with Peroxi-
dasin, a classical plasmatocyte marker, in first instar larvae
demonstrated that at this stage, all Peroxidasin-positive cells
do not express hml (Fig. 3C–E). These data are in favor of
hml being expressed in only a subpopulation of the plas-
matocyte lineage.
We then analyzed circulating hemocytes from wasp-
infected third instar larvae. Indeed, parasitoid Hymenoptera
lay their eggs in young Drosophila larvae, thereby eliciting
a strong cellular response with differentiation of numerous
lamellocytes, the hemocyte type responsible for encapsula-
tion of parasites. We could not detect hml expression in
lamellocytes, either in circulation or in the process of en-
capsulating a wasp egg (Fig. 3F and G, and Fig. 3H and I,
respectively). Finally, we labeled lymph glands from third
instar larvae with an anti-proPO antibody, which is a marker
for crystal cells (Fig. 3J–L). We observed that a subpopu-
lation of proPO-positive cells express GFP (Fig. 3J–L),
indicating that hml is also expressed in a subset of crystal
cells. Taken together, these results show that hml is ex-
pressed in a subpopulation of plasmatocytes and of crystal
cells, but not in lamellocytes.
Functional analysis of Hml by RNAi
In order to characterize the function of Hml, we utilized
heritable and tissue-specific RNAi technique caused by the
expression of an inverted repeat (IR) sequence of the target
gene (Kennerdell and Carthew, 2000). For this, we gener-
ated transgenic lines (UAS-hml RNAi) harboring an IR
sequence of hml cDNA under the control of UAS, and
crossed them with hml-GAL4 flies. As a negative control,
the hml-GAL4 line was crossed with yw. Western blotting of
protein extracts from third instar larvae indicated a dramatic
Hml reduction in hml RNAi larvae compared with the
control cross (Fig. 4A).
The hml-GAL4; UAS-hml RNAi combination is not le-
thal. Larvae and adults do not display any obvious devel-
opmental defect under normal conditions. Even if we use
daughterless-GAL4 (da-GAL4) to drive UAS-hml RNAi
ubiquitously, they also show no obvious developmental
defect, indicating that Hml is not required for viability (data
not shown). Since Hml bears domains that are conserved in
von Willebrand Factor (VWF), and that mutations in the
VWF result in prolonged bleeding known as von Wille-
brand disease (reviewed in Perutelli et al., 1997), the hml
RNAi larvae were tested for possible bleeding defects. For
this, we pricked them with a thin needle (Fig. 4). In contrast
to the limited melanized spot at the site of injury on control
larvae, an expanded melanized spot was observed on hml
RNAi larvae (upper panel of Fig. 4B). To estimate differ-
ences in hemolymph bleeding after injury, we set up the
following bleeding test. A total of 35 larvae from either
control or hml RNAi larvae were injured, transferred to a
filter paper wettened with minimal hemolymph buffer, and
kept in a plastic dish cooled on ice to suppress larval
movement. After 3 h of bleeding on ice, the larvae were
removed, and the filter paper was kept at 25°C for the
completion of the melanization reaction (lower panel of Fig.
4B). Compared with controls, hml RNAi larvae had pro-
duced a significantly larger black blot, indicating that the
amount of hemolymph bleeding in hml RNAi is much
higher than that of control larvae. Four independent exper-
iments were performed which produced the same results.
Fig. 2. Developmental hml expression. To visualize hml expression, hml-GAL4 flies were crossed with UAS-eGFP flies. Stage 17 embryo (A and B), first
instar larva just before hatching (C and D), and first instar larva (E and F) are shown under phase contrast (A, C, E) or with an epifluorescence microscope
(B, D, F). GFP expression is restricted to hemocytes. (G) In a third instar larvae, GFP is also seen in sessile hemocytes (arrowheads) and in the lymph gland
(arrow). (H, I) The lymph gland hml expression is localized in cells from the anterior most lobes. Bar, 100 m.
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Since there was no size difference between control and hml
RNAi larvae, this defect cannot be due to different initial
hemolymph volume.
We then addressed the question of whether the observed
bleeding defect was caused by a defect of the melanization
reaction. For this, total melanin production (which gives the
amount of activable proPO in the hemolymph) as well as
PO activity after immune challenge (which gives the
amount of proPO that has been activated) were measured.
Three independent hemolymph samples collected from ei-
ther control or hml RNAi larvae were mixed with LPS
solution and spotted on a glass slide to allow the blackening.
There was no significant difference in the intensity of the
black spots, indicating that hemolymphs contained roughly
the same amount of proPO (Fig. 4C). In addition, all spots
melanized with the same kinetics (data not shown). We
measured PO activity in hemolymph samples from adult
flies 4 h after infection with a mixture of Gram-negative and
Gram-positive bacteria (Fig. 4D). Again, there was no sig-
nificant difference between control and hml RNAi larvae. In
addition, wasp infection on hml RNAi larvae also leads to
clear melanized wasp egg encapuslation (data not shown).
These experiments indicate that proPO synthesis and func-
tionality are wild-type in hml RNAi larvae and that the
bleeding defect is likely related to another mechanism.
We further addressed the question of whether the expres-
sion of antimicrobial peptides is affected on hml RNAi
adults. For this, UAS-hml RNAi flies were crossed with
either yw (as a control), hml-GAL4, or da-GAL4 flies, the
progenitors were infected with either Gram-positive (M.
luteus) or Gram-negative bacteria (E. coli), and the expres-
sion of antimicrobial peptides for Drosomycin (Drs) (which
is the target molecule of Toll pathway against Gram-posi-
tive bacteria) and Diptericin (Dip) (which is the target
molecule of Imd pathway against Gram-negative bacteria)
were analyzed (Fig. 5). Induction of both Drs and Dip
expression was not significantly affected, suggesting that
Hml is not required for both Toll and Imd signaling cas-
cades.
Discussion
Two distinct hematopoietic phases are observed in Dro-
sophila: the first in embryos and the second at larval stages.
Embryonic hemocytes first appear in stage 10 embryos, in
the head mesoderm, and disperse along several migratory
paths throughout the embryos (Tepass et al., 1994). In larval
stage, the lymph gland is responsible for generating larval
hemocytes (Lanot et al., 2001). However, it is still unclear
how this transition occurs: are the population of larval
hemocytes only derived from lymph glands or mixed with
embryonic hemocytes? Since hml expression visualized by
GFP is already observed in stage 17 embryos in a small
population of embryonic hemocytes which expands rapidly
and is still present in hatching larvae, this is the first indi-
cation that embryonic hemocytes persist and contribute to
the hemocyte population at larval stages. In third instar
larvae, hml expression is exclusively seen in the anterior
Fig. 3. Cell-specific hml expression analyzed in hml-GAL4;UAS-eGFP
larvae. (A, B) Circulating plasmatocytes from a third instar larva were
observed under phase contrast (A) and epifluorescence (B). (C–E) First
instar larval hemocytes were stained by anti-Peroxidasin antibody and
analyzed by confocal microscopy. Plasmatocytes expressing either Hml
(green in C), Peroxidasin (red in D), or both (yellow in E which is the
merged image) are shown. Asterisks indicate plasmatocytes which do not
express Hml (A–E). (F–I) Hemolymph from larvae parasitized with Lep-
topilina boulardi, which triggers differentiation of lamellocytes (shown as
L). Arrow in (F) and (G) indicates a plasmatocyte expressing Hml. A low
magnification picture to visualize an encapsulated and melanized wasp egg
(arrowhead in H and I) is shown. The wasp egg is encapsulated by
lamellocytes which do not express hml (H). (J–L) Lymph gland from a
third instar larva stained with anti-proPO antibody to visualize crystal cells.
An anterior most lobe is shown (as a white dashed line) as observed by
confocal microscopy. Cells expressing hml (green in J), proPO (red in K),
or both (yellow in L) are observed. Asterisks and arrows indicate cells
which express only proPO or both, respectively. Bars, 50 m.
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lobes of lymph glands which contain numerous secretory
cells, plasmatocytes, few crystal cells, and a number of
undifferentiated prohemocytes, but not in the posterior
lobes which contain essentially prohemocytes. In addition
to that, hml expression is also observed in both circulating
and segmentally distributed sessile hemocytes. These re-
sults suggest that hml is only expressed in fully differenti-
ated larval hemocytes. Interestingly, this expression is re-
stricted to a subpopulation of both plasmatocytes and crystal
cells, but is never found in lamellocytes. hml always coex-
pressed with either Peroxidasin or proPO. We did not ob-
serve cells that only express hml. Since we cannot distin-
guish the difference between cells only expressing
Peroxidasin or proPO, and cells which express them to-
gether with hml in terms of morphology, hml might be a
novel marker for hemocyte classification.
Hml shares conserved domains with human VWF (Goto
et al., 2001b). The human VWF is a large multimeric blood
glycoprotein essential for the blood clotting and platelet
thrombus formation (hemostasis) (reviewed in Ruggeri,
2003). The role of VWF in thrombus formation is mainly
classified into two functions. Firstly, it mediates the plate-
lets adhesion to components of the extracellular matrix.
Secondly, by associating with blood cofactor VIII, it pre-
vents the rapid disappearance of this cofactor from plasma
for normal thrombin generation (Nogami et al., 2002). Un-
like most other proteins, the majority of VWF is constitu-
tively secreted from human umbilical vein endothelial cul-
Fig. 4. Functional analysis of Hml by heritable and tissue-specific RNA interference. (A) UAS-hmlRNAi flies were crossed with either yw (control) or
hml-GAL4 flies (hml RNAi). The larval extracts were analyzed by Western blotting using Hml mAb (Anti-Hml). Immunodetection with an antiserum against
laminin  chain was carried out (Anti-lan) in parallel to confirm gene-specific interference. (B) Control or hml RNAi third instar larvae were pricked with
a thin needle. Upper panels show the injury site. Lower panel shows total bleeding of 35 individuals from either cross. (C) Total amounts of melanin in
circulation were measured by hemolymph spotting. Three independent hemolymph spots are indicated as 1, 2, and 3. The picture was taken after 1 h of
hemolymph melanization. (D) Phenoloxidase activity was measured after infecting adults with a mixture of Gram-positive (Micrococcus luteus) and
Gram-negative (Escherichia coli) bacteria.
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tured cells as a dimeric form, whereas the largest
biologically potent multimers are stored in storage or-
ganelles, such as Weibel-Palade body in endothelial cells
and the -granule in megakaryocytes and platelets, and
released after stimulation by secretagogues (Mayadas and
Wagner, 1991). The immunoprecipitation analysis using
Hml antibody indicated that the majority of Hml is secreted
as a dimeric form; however, we could not detect the largest
multimers even if stimulated by calcium ionophore A23187
in Drosophila cell culture (Goto et al., 2001b). Qualitative
or quantitative abnormalities of VWF cause typical com-
mon inherited bleeding disorder, von Willebrand disease.
Diseases that are similar to von Willebrand disease have
been reported in other mammalian species, such as pig, dog,
and mouse (Denis and Wagner, 1999). In addition, VWF
knock out mice have recently been produced which exhibit
prolonged bleeding and leukocyte recruitment defect (Denis
et al., 1998, 2001). Consistent with the viable and fertile
phenotype of the VWF knock out mice, hml RNAi mutants
are also viable and fertile without any obvious developmen-
tal defects. Interestingly, in hml RNAi larvae, we observed
aggravated bleeding after septic injury which suggests the
existence of conserved hemostasis mechanisms in mammals
and insects. We confirmed that the prolonged bleeding of
hml RNAi larvae is not due to defects of melanization
reaction. This observation contrasts with the recent report
that the melanization process is involved in wound healing
and bleeding control (Ra¨met et al., 2001). Thus, Hml func-
tion contributes to a different aspect of the sealing of a
wound, possibly by participating in coagulation. Other im-
mune function for Hml has so far not been detected. We
have recently established hml RNAi in Drosophila cell
culture (Goto et al., 2001a,c) and did not observe a signif-
icant defect in the inducibility of the antimicrobial peptide
attacin by heat killed gram-negative bacteria in these cells
(data not shown) (Tauszig-Delamasure et al., 2002). More-
over, hml RNAi flies after microbial infection showed no
significant defects for Drs and Dip expression in which is so
far known as target molecules for Toll and Imd pathway,
respectively (reviewed in Hoffmann and Reichhart, 2002) (Fig.
5). It is thus likely that hml does not play a pivotal role in
Drosophila humoral response. It is not clear at this point why
a loss-of-function of hml leads to prolonged bleeding. Since
VWF mediates the aggregation of platelets at the site of vas-
cular injury by bridging many molecules, including glycopro-
tein receptors, integrins, and fibrillar collagens (Cooney and
Ginsburg, 1996; Ruggeri, 2000; Cruz et al., 1995; Lankhof et
al., 1996), it is possible that Hml contributes to hemocyte
aggregation by interacting with other proteins. Further bio-
chemical and genetic analyses to identify proteins that interact
with Hml will tell us to which extent hemostasis mechanisms
are conserved among insects and mammals.
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